Sartorius Stedim Biotech SA
PAR:DIM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
PAR:DIM
|
FR |
Intrinsic Value
The intrinsic value of Sartorius Stedim Biotech SA (DIM) under the Base Case is 216.36 EUR per share.
Compared with the current market price of 210.6 EUR, the stock appears
Undervalued by 3% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Sartorius Stedim Biotech Does
Sartorius Stedim Biotech makes tools and consumable products used to develop and manufacture biologic drugs. Its main products include filters, bags, tubing, fermentation and cell-culture equipment, and lab instruments that help scientists grow cells, separate liquids, and keep production sterile. It is a supplier to the life-science supply chain rather than a drug maker itself.
- Headquarters
- France FR
- Employees
- 10 456
- IPO date
- Oct 20, 1994
Sartorius Stedim Biotech has no economic moat
Customers can choose among Sartorius Stedim and established suppliers such as Danaher, Merck, and Thermo Fisher, whose products cover many of the same steps in biopharmaceutical production. Sartorius’s products do not become more useful just because more customers use them, so competitors can still compete for buyers.
Read the full moat analysis
Revenue & Expenses Breakdown
Sartorius Stedim Biotech SA
Earnings Waterfall
Sartorius Stedim Biotech SA
The intrinsic value for Sartorius Stedim Biotech SA (DIM) under the Base Case is 216.36 EUR.
Compared with the current market price of 210.6 EUR, the stock appears Undervalued by 3% .